IR
Superintel
Overview
Markets
Watchlist
More
Protalix Biotherapeutics Inc
Q1 2024 vs Q2 2024
Comparing institutional holders between quarters
Quarters
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile
3
Filed
0
New
0
Closed
0
Increased
0
Decreased
3
Unchanged
0
No Data
Sort by
Q2 2024 shares — high to low
Q2 2024 shares — low to high
Share change — largest gain
Share change — largest cut
% change — largest gain
% change — largest cut
Q2 2024 value — high to low
Value change — largest gain
Value change — largest cut
Institution — A to Z
Filed — newest first
Highbridge Capital Management LLC
UNCHANGED
Shares
12,500,000
from 12,500,000
Change
0
(0%)
Value
$12.9M
(-$172.5K)
Filed 2024-08-12
Citigroup Inc
UNCHANGED
Shares
2,500,000
from 2,500,000
Change
0
(0%)
Value
$2.6M
(+$84.0K)
Filed 2024-08-12
Proequities, Inc.
UNCHANGED
Shares
0
from 0
Change
0
Value
$0
($0)
Filed 2024-07-23
Institution
Status
Q2 2024 ↓
Q1 2024
Change
% Change
Q1 2024 Value
Q2 2024 Value
Value Change
Filed
Highbridge Capital Management LLC
UNCHANGED
12,500,000
12,500,000
0
0%
$13.1M
$12.9M
-$172.5K
2024-08-12
Citigroup Inc
UNCHANGED
2,500,000
2,500,000
0
0%
$2.6M
$2.6M
+$84.0K
2024-08-12
Proequities, Inc.
UNCHANGED
0
0
0
—
$0
$0
$0
2024-07-23
Showing 3 of 3 institutions